MedPath
HSA Approval

DANEURON TABLET

SIN12077P

DANEURON TABLET

DANEURON TABLET

September 17, 2002

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Therapeutic

Pharmacy Only

Formulation Information

TABLET, FILM COATED

**Dosage and Administration :** One film coated tablet daily, it can be increased up to 3 film coated tablets daily as required.

ORAL

Medical Information

**Indications :** DANEURON promotes effectively the treatment of pain due to disturbance of the peripheral nerves such as lumbago, neuritis, polyneuritis, post-herpetic neuralgia. It is also effective in the treatment of hyperemesis gravidarum and during the convalescent period of disease.

**Contraindications :** None reported so far.

A11DB

维生素B1与维生素B6和/或B12的复方

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

PT. HEXPHARM JAYA LABORATORIES

Active Ingredients

PYRIDOXINE

200 mg

Pyridoxine

CYANOCOBALAMIN

200 mcg

Vitamin B12

THIAMINE

100 mg

Thiamine

Documents

Package Inserts

Daneuron FCT PI.pdf

Approved: April 21, 2023

Download
© Copyright 2025. All Rights Reserved by MedPath